INTRODUCTION
Mitochondria are the intracellular organelles responsible for ATP synthesis through the coupling of oxidative phosphorylation to respiration in human and animal cells. Under normal physiological conditions, a small fraction of oxygen consumed by mitochondria is converted to superoxide anions, H # O # and other reactive oxygen species (ROS) [1] . Moreover, mitochondrial respiratory function has been demonstrated to decline in various human tissues during the aging process [2, 3] . This is thought to be caused, at least partly, by oxidative damage and mutation of mitochondrial DNA (mtDNA) in somatic tissues of aged individuals [3] .
Recently, we found that mtDNA copy number is increased in the lung tissues of elderly human subjects [4] . Moreover, we showed that mtDNA mutation, oxidative DNA damage and lipid peroxidation are increased during aging in the human lung [4] [5] [6] [7] and other tissues [8, 9] . These findings are consistent with a previous report that mtDNA contents are increased in the tissues of old rats [10] and of elderly subjects [11] . This increase in the content of mtDNA was thought to compensate for respiratoryfunction decline during the aging process [12] . However, the molecular mechanism underlying the increase of mtDNA associated with respiratory-function decline in human aging remains unclear.
Mitochondria are the major intracellular source and primary target of ROS, which are generated under normal conditions as by-products of aerobic metabolism in animal and human cells. It
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pendent manner. Moreover, the oxidative stress induced by buthionine sulphoximine was also found to cause an increase in mitochondrial mass of the treated cells. Increased uptake of a vital mitochondrial dye Rhodamine 123 and enhanced tetrazolium [MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] reduction revealed that the mitochondria increased by H # O # treatment were functional. In addition, the increase in the mitochondrial mass was also observed in cell-cycle-arrested cells induced by mimosine, lovastatin and genistein. Taken together, these findings suggest that the increase in mitochondrial mass and mtDNA content are the early molecular events of human cells in response to endogenous or exogenous oxidative stress through cell-cycle arrest.
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has been established that defects in the respiratory chain lead to enhanced production of ROS and free radicals in mitochondria [13] [14] [15] . Moreover, H # O # has been proposed to play a role as a secondary messenger in signal-transduction pathways [16, 17] . The increase of ROS and enhanced oxidative stress stimulates the expression of early growth-related genes such as c-fos and cjun [18] . Recently, H # O # was proposed to be involved in the communication between mitochondria and the nucleus [19, 20] . Therefore, we hypothesized that the age-dependent increase in the production of superoxide anions and H # O # from mitochondria is one of the factors involved in feedback compensation for the decline of respiratory function during the aging process [21] .
To test this hypothesis, we exposed MRC-5, a human lung fibroblast cell line, to oxidative stress by treatment with low concentrations of H # O # or buthionine sulphoximine (BSO). The effect of oxidative-stress treatment on the copy number of mtDNA and mitochondrial mass in the cell was investigated.
MATERIALS AND METHODS

Cell culture
Human lung fibroblasts, from the MRC-5 cell line, were cultured at 37 mC in humidified 5 % CO # \95 % air in Dulbecco's modified Eagle's medium (Gibco\BRL, Bethesda, MD, U.S.A.) supplemented with 10 % fetal bovine serum, 50 units\ml penicillin G
Figure 1 Cell growth and viability of MRC-5 cells treated with H 2 O 2
MRC-5 cells were treated with H 2 O 2 at concentrations from 90 to 360 µM. After treatment for 24-72 h, cells were enumerated using a haemocytometer (A), and the number of viable cells was determined by Trypan Blue exclusion (B). Data points represent measured valuespS.D. of two independent experiments performed on cells from three separate dishes. The differences in growth kinetics and viability between untreated and H 2 O 2 -treated cells were found to be statistically significant by using one-way ANOVA (*, P 0.05).
and 50 mg\ml streptomycin sulphate. Cells were subjected to a 1 : 2 split every 4 days.
Oxidative-stress treatment
Oxidative-stress treatment was performed on cells that had all been cultured at the same density. 
Treatment with drugs affecting the cell cycle
To arrest the cell cycle, cells were treated with 200 µM mimosine, 2.5 µM lovastatin or 50 µM genistein (Sigma) for 24 h. The treated cells were then washed once with Hanks ' balanced salt solution and were harvested by trypsinization at various time points for cell-cycle analysis and mitochondrial-mass determination.
Cell growth and viability assay
Cells were harvested by trypsinization and resuspended in 1 ml of Medium 199 (Gibco\BRL). The cells were enumerated using a haemocytometer, and the number of viable cells was determined on the basis of their exclusion of 0.4 % Trypan Blue.
Cell-cycle analysis
After treatment with H # O # or other chemicals, cells were trypsinized and resuspended in 70 % ethanol. The cells were incubated on ice for at least 1 h and resuspended in 1 ml of cell-cycle assay buffer (0.38 mM sodium citrate, 0.5 mg\ml RNase A and 0.01 mg\ml propidium iodide) at a concentration of 5i10& cells\ml. Samples were stored in the dark at 4 mC until cell-cycle analysis, which was carried out by use of a flow cytometer and ModFit LT 2.0 software (Verity Software, Topsham, ME, U.S.A.).
Determination of mitochondrial mass
The fluorescent dye 10-n-Nonyl-Acridine Orange (NAO ; Molecular Probes, Eugene, OR, U.S.A.), which binds specifically to cardiolipin at the inner mitochondrial membrane independently of membrane potential (∆Ψ m ) [22, 23] , was used to monitor the mitochondrial mass [24] . Cells were trypsinized and resuspended in 0.5 ml of Medium 199 containing 10 µM NAO or 10 µM MitoTracker Green FM (Molecular Probes), which is preferentially accumulated in mitochondria regardless of mitochondrial membrane potential. After incubation for 10 min at 25 mC in the dark, cells were transferred immediately to a tube on ice for flow-cytometric analysis.
Dichlorofluorescin staining
production by cultured cells was measured using the probe 2h,7h-dichlorofluorescin diacetate (DCFH-DA ; Molecular Probes) [24] [25] [26] . This probe is accumulated by cells and hydrolysed by cytoplasmic esterases to become 2h,7h-dichlorofluorescin, which then reacts with H # O # to give the fluorescent product 2h,7h-dichlorofluorescein (DCF) [25] . Cells were incubated with 5 µM DCFH-DA in culture medium for 30 min at 37 mC and then washed, resuspended in 0.5 ml of PBS, and submitted to flowcytometric analysis.
Measurement of mitochondrial membrane potential
Cells were trypsinized and resuspended in 0.5 ml of Medium 199 containing 0.5 µg\ml Rhodamine 123 (Molecular Probes) or 3,3h-dihexyloxacarbocyanine iodide [DiOC ' (3) ; Molecular Probes]. After incubation for 30 min at 37 mC in the dark, cells were transferred immediately to a tube on ice for analysis of the fluorescence intensity by flow cytometry. The excitation wavelength was set at 488 nm. The observation wavelength of 530 nm was chosen for green fluorescence and 585 nm for red fluorescence and the intensities of emitted fluorescence were collected on FL1 and FL2 channels, respectively. In each measurement, a minimum of 20 000 cells were analysed. Data were acquired and analysed using the Cell Quest software (Becton Dickinson). Relative change in the mean fluorescence intensity was calculated as the ratio between mean fluorescence intensity in the channel of the treated cells and that of the control cells.
Flow-cytometric analysis
Southern-blot hybridization
For Southern-blot analysis, 5 µg of total DNA of the treated and control cells were linearized by digestion with BamHI (Boehringer Mannheim, Mannheim, Germany), and the digested DNA was electrophoresed at 50 V for 12 h in a 1.0 % agarose gel. DNA bands in the gel were denatured and transferred on to a Hybond N + nylon membrane (Amersham, Little Chalfont, Bucks., U.K.). Hybridization with a [α-$#P]dCTP-labelled human mtDNA probe of the D-loop region (spanning nucleotide positions 16455-1462) was carried out at 65 mC for 2 h in a rapid hybridization buffer (Amersham). The filter was washed with 2iSSC\0.1 % SDS (where 1iSSC is 0.15 M NaCl\0.015 M sodium citrate) for 15 min at room temperature and then washed twice with 0.1iSSC\0.1 % SDS for 15 min at 65 mC. The washed filter was wrapped with Saran Wrap (' clingfilm ') and subjected to autoradiography.
MTT reduction assay
Cells were treated with H # O # at the concentrations from 90 to 360 µM as described above. After 48 h of incubation, cells were harvested and cell viability was determined by the Trypan Blueexclusion method. For determination of mitochondrial function, we incubated the cells with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT ; Sigma) at a final concentration of 2.0 µg\ml during the last 2 h of the incubation period. The cells were lysed with DMSO and the absorbance at 570 nm was measured. An MTT reduction index was calculated as the ratio between the absorbance at 570 nm and the number of viable cells [27] .
Statistics
Data are presented as meanspS.D. except where indicated. Comparisons among multiple groups were made by a one-way analysis of variance (ANOVA) followed by Fisher's protected least significant difference post hoc test. The differences with P 0.05 were considered significant. Figure 1(A) and 1(B Figure 1A) . Most of the cells treated with 180 or 360 µM H # O # appeared enlarged, flattened, and less spindleshaped as compared with the control cells at the end of 24-h treatment (results not shown). We also found that the viability of the cells treated with 180 or 360 µM H # O # was lower than that of the control cells (P 0.05), but still remained 80 % after 72-h treatment ( Figure 1B) . Furthermore, we found that 24 h after treatment the percentage of cells in G ! and G " phases was increased (Figure 2A) , and that the percentage of cells in the S phase decreased as a function of H # O # concentration ( Figure  2B) .
RESULTS
After treatment
In an attempt to determine whether H # O # leads to the proliferation of mitochondria, we used the fluorescent dye NAO to monitor the mitochondrial mass [22] [23] [24] . After treatment for 24-72 h with the indicated concentrations of H # O # , the relative NAO intensity of the treated cells was found to be significantly higher than that of the untreated cells (P 0.05, Figure 3 In addition to the oxidative stress induced by H # O # , BSO, an inhibitor of the glutathione biosynthetic pathway, was used to treat the cultured cells. After treatment with 1 or 2 mM BSO, we found that the concentration of ROS in the cells, as revealed by staining with DCFH-DA, increased with time (P 0.05, Figure  4A ). After treatment for 72 h with 1 or 2 mM BSO, the relative intensity of NAO of the treated cells was increased to 1.6-or 2.2-fold as compared with that of the control cells, respectively (P 0.05, Figure 4B ). These results indicate that not only H # O # but also glutathione depletion can lead to an increase in the number of mitochondria in MRC-5 cells.
Using Southern-blot hybridization, we determined the mtDNA content of the MRC-5 cells after treatment with 180 µM H # O # for 24-72 h. We found that the mtDNA content of the treated cells was higher than that of the untreated cells and increased with the duration of incubation ( Figure 5 ). This increase of mtDNA content was consistent with the observation of proliferation of mitochondria in the H # O # -treated cells as revealed by NAO staining.
To analyse whether the extra mitochondria in the H # O # -treated cells were functional, we measured mitochondrial membrane potential of the treated cells by staining with Rhodamine 123 [25] . The relative intensity of Rhodamine 123 of the H # O # -treated cells was significantly higher than that of the control cells and was increased with the duration of incubation (results not shown). The increase in mitochondrial membrane potential correlated well with the increase in mitochondrial mass throughout the 48 h period of the experiment (r l 0.982, P 0.0001, Figure 6 ). The mitochondrial membrane potential per unit mitochondrial mass, expressed as the ratio of fluorescence intensity of Rhodamine 123 to that of NAO, appeared to be similar throughout the 48 h of the experiment (Figure 6 ). Moreover, we observed similar results using another fluorescent dye, DiOC ' (3), the uptake of which is sensitive to mitochondrial membrane potential (results not shown). For the assessment of mitochondrial function, we analysed the capacity of H # O # -treated cells to reduce MTT. We found that although the number of the viable cells after H # O # treatment was significantly decreased (P 0.05), the absorbance at 570 nm of the remaining cells was only slightly decreased as compared with the untreated cells ( Figure 7A ). An arbitrary MTT reduction index, calculated as the ratio between the absorbance at 570 nm and the corresponding number of viable cells, revealed a significant increase in the relative MTT activity (P 0.05, Figure  7B ). These results indicate that the mitochondria increased in the H # O # -treated cells were functional. To test whether the alteration of mitochondrial mass and mtDNA copy number in the cell might be uncoupled from the cell-cycle-controlled biosynthesis of chromosomal DNA, we treated MRC-5 cells with mimosine, lovastatin or genistein, which cause cell-cycle arrest. We found that after 24 h of treatment the cell cycle was arrested at the late G " , G ! \G " and G # \M phases by mimosine, lovastatin and genistein, respectively ( Figure 8 ). Moreover, after 48 h of treatment the relative intensity of NAO of the treated cells was increased to 2.3-, 1.7-and 2.1-fold, respectively, as compared with that of the control cells (P 0.05, Figure 9 ).
DISCUSSION
Each human and animal cell contains between several hundred and over a thousand mitochondria, each carrying 2-10 copies of mtDNA. The mitochondrial mass and mtDNA copy number of individual cells vary with the type of the cell and tissue, and are changed during cell differentiation, hormone treatment and exercise [28] [29] [30] [31] .
In the present study, we observed growth arrest in human lung fibroblasts treated with low concentrations of H # O # (Figures 1  and 2 ). It is apparent that H # O # at concentrations of between 90 and 180 µM increased the population-doubling time and that 360 µM H # O # caused a permanent growth arrest. Most of the treated cells exhibited significant alterations in morphology as compared with the control cells. The results are consistent with the previous observations that H # O # at sublethal concentrations can induce senescence-like growth arrest in human cells [32, 33] . Moreover, we found in this study that the oxidative stress induced by sublethal concentrations of H # O # caused an increase in the amount of mitochondria and mtDNA of the treated cells and that the increased mitochondria were functional. Furthermore, the oxidative stress induced by reduction of the intracellular glutathione level with BSO was also found to increase mitochondria in the treated cells (Figure 4) . In a separate experiment, we exposed MRC-5 cells to 20 µM antimycin A and observed that the ROS generation in the treated cells was increased 2-fold compared with that of the untreated cells after 30 min of treatment. Moreover, after treatment for 72 h, we found that the relative intensity of NAO in the treated cells was increased to 2.6-fold compared with that of the control cells. This is consistent with the observation that by partial inhibition of respiratory function by antimycin A, the expressions of both cytochrome c " and cytochrome b are increased in human fibroblasts [34] . Moreover, intracellular H # O # level was found to increase within 3 h prior to expression of these genes. These results indicate together that mild oxidative stress can trigger cell-cycle arrest and lead to an increase of mitochondrial mass and mtDNA in human cells.
Increases of mitochondria and mtDNA synthesis have been observed to occur in the absence of nuclear DNA replication [35] . The alteration of mitochondrial mass and mtDNA in the cell might be uncoupled from the cell-cycle-controlled biosynthesis of chromosomal DNA. To confirm this, we treated MRC-5 cells with lovastatin, genistein or mimosine and observed that these drugs caused cell-cycle arrest (Figure 8 ). In addition, the mitochondrial mass was increased, to a different extent, in the cells after 48 h of treatment ( Figure 9 ). It is worth noting that the amplitude of increase of the mitochondrial mass in the cells treated with the cell-cycle-arresting drugs was similar to that in the H # O # -treated cells within the same treatment period. The results imply that whereas overall cell division was arrested by H # O # or the drugs, mitochondrial biogenesis was unaffected and that mitochondria continued to proliferate as if the cells were going to divide. Thus, mild oxidative stress may induce an increase of mitochondria and mtDNA via a pathway that bypasses cell-cycle control.
Increase of mitochondria has also been observed in some tumour cells treated with herbimycin A and genistein [24, 27] . Mancini et al. [24] found that herbimycin A, a tyrosine kinase inhibitor, induces cell-cycle arrest in G # \M and results in a marked accumulation of mitochondria in a human colon carcinoma cell line (Colo-205). In addition, the G # \M cell-cycle arrest and increase of mitochondrial number and\or function were also observed in three tumour cell lines (MCF-7, human breast tumour ; Jurkat cells, human T-cell leukaemia ; and L-929, mouse transformed fibroblasts) after treatment of genistein [27] . The results obtained in these studies are consistent with our findings and support the notion that the cell-cycle arrest induced by oxidative stress plays a critical role in the increase of mitochondria and mtDNA.
Furthermore, it has been found that the relative content of mtDNA is increased with age and that the mtDNA content is correlated with the level of oxidative damage to DNA in human lung tissues [4] . Both oxidative DNA damage and lipid peroxidation are enhanced during aging in the human lung [4] [5] [6] [7] , indicating that there is a higher oxidative stress in the tissues of aged individuals. Therefore, the endogenous and\or exogenous oxidative stress in the lung of elderly subjects may cause cellcycle arrest and thereby increase the amount of mitochondria and mtDNA in lung tissues.
In summary, we have demonstrated clearly for the first time that oxidative stress induced by H # O # leads to an increase of mitochondria and mtDNA in human lung fibroblasts. Moreover, the mitochondria increased by H # O # -elicited oxidative stress are functional. We therefore suggest that the increase in mitochondrial mass and mtDNA content may be one of the early molecular events gearing the human cells up to respond to endogenous or exogenous oxidative stress through cell-cycle arrest.
